Boehringer Ingelheim Venture Fund Overview

  • Investor Type

  • Venture Capital

  • Status

  • Active

  • Professionals

  • 15

Professionals
  • Investments

  • 88

  • Portfolio

  • 39

  • Exits

  • 16

Exits

Boehringer Ingelheim Venture Fund General Information

Description

Founded in 2010, Boehringer Ingelheim Venture Fund is a venture capital based in Ingelheim am Rhein, Germany. The seeks prefers to invest in companies operating in the healthcare sector.

Contact Information

Website
www.boehringer-ingelheim-venture.com
Year Founded
2010
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Corporate Venture Capital
Primary Office
  • Binger Straße 173
  • 55216 Ingelheim am Rhein
  • Germany

Boehringer Ingelheim Venture Fund Investments (88)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Rewind Therapeutics 25-Jan-2023 Later Stage VC Drug Discovery Generating Revenue 000000000 00000 00.0
000000 00000000000 29-Nov-2022 00000 00000 0000 Drug Discovery Generating Revenue 000 0000 00.0
00000000 03-Nov-2022 00000 00000 0000 Biotechnology Pre-Clinical Trials 000 00 00.0
0000000000 15-Sep-2022 00000 00000 0000 Decision/Risk Analysis Generating Revenue
0-00 0000000 00000 01-Sep-2022 0000 00000 00.000 Monitoring Equipment Generating Revenue 000000000 000000
000000 00000000000 13-Jul-2022 00000 00000 00000 Drug Discovery Pre-Clinical Trials
0000000 0000000000 10-Jun-2022 00000 00000 00000 Drug Discovery Clinical Trials - Phase 2
00000000 03-Mar-2022 0000 00000 0000 Drug Discovery Startup 000 0000 00.0
Centauri Therapeutics 26-Jan-2022 Later Stage VC 000.00 Drug Discovery Generating Revenue 00000000 000000000 00.0
Brainomix 16-Dec-2021 Later Stage VC 000.00 Diagnostic Equipment Generating Revenue 000000 00000
You’re viewing 10 of 88 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Boehringer Ingelheim Venture Fund Exits (16)

Company Name Exit Date Exit Type Exit Size
Anagenesis Biotechnologies 05-Dec-2022 Bankruptcy: Liquidation
0000000 0000000000 01-Jul-2022 000 00 00000000
000000 000000000 21-Sep-2021 000000000000000000
000 000000000000 01-Dec-2020 000000000000000000 00.00
0000000 20-Apr-2020 000000000000000000
0000 000000000000 15-Jul-2019 000000000000000000 00000
00000 000000000000 01-Jun-2019 000000000000000000 00000
0000000 000000 18-Apr-2019 000 0000
ICD Therapeutics 29-Mar-2019 Merger/Acquisition
ViraTherapeutics 13-Sep-2018 Merger/Acquisition 00000
You’re viewing 10 of 16 exits. Get the full list »

Boehringer Ingelheim Venture Fund Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Boehringer Ingelheim Venture Fund Team (30)

Name Title Deals Funds Boards Office
Fei Shen Ph.D Managing Director, USA 0 0 0 Ingelheim am Rhein, Germany
Frank Kalkbrenner Ph.D Global Head, Director & Investment Manager 00 0 0 Ingelheim am Rhein, Germany
Markus Barner Executive Ingelheim am Rhein, Germany
Oliver Reuss Executive Director & Investment Manager 0 0 0 Ingelheim am Rhein, Germany
Philipp Mueller Ph.D Executive Director & Investment Manager 0 0 Ingelheim am Rhein, Germany
You’re viewing 5 of 30 team members. Get the full list »

Boehringer Ingelheim Venture Fund Co-Investors (150)

Name With Exits Lead Partner Series Industry
High-Tech Gründerfonds 5 0 Series chart Industry bar
Korea Investment Partners 0 0 0 Series chart Industry bar
Andera Partners 0 0 Series chart Industry bar
Evotec 0 0 Series chart Industry bar
Novo Holdings 0 0 Series chart Industry bar
You’re viewing 5 of 150 co-investors. Get the full list »